Why the study?
Advances in imaging, computational science, and multi-omic approaches have yielded new insights into phenotypes and sub-phenotypes within the existing clinical classification of pulmonary hypertension.
Population
Patients with pulmonary hypertension (PH)
Design
Review
Authors
Loading...
May inform future PH trial design; leaves open whether sub-phenotypes improve prognostication or therapy selection.
Emerging phenotypes in pulmonary hypertension, identified through multi-omic and advanced imaging approaches, have the potential to improve prognostication, clinical trial design, and precision therapies.
Weatherald et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: